Filing Flows

Filing Flows › CareDx (CDNA) › Next earnings date

CareDx (CDNA) earnings: beat the estimate

CareDx (CDNA) reported on Oct 29, 2026 and beat the EPS estimate: $0.70 against $0.26 (+174.5%). Revenue was $139M for Q3 2026, +39% year over year. It beat the EPS estimate in 80% of the quarters on record.

Last result+174.5% vs estimate
Beat rate80%

The last report

CareDx reported revenue of $139M for the third quarter 2026 (+39% Y/Y), net earnings $19.3M: Testing services revenue $119M, Patient and digital solutions revenue $20.2M. How it makes money → · Every quarter →

CareDx: EPS against the estimate, last 5 reportsCareDx: EPS against the estimate, last 5 reportsEstimateReported$0.14$0.28Nov 25$0.23$0.12Feb 26$0.13$0.34Apr 26$0.23$0.37Jul 26$0.26$0.70Oct 26
Latest (Oct 26): Estimate $0.26, Reported $0.70.
CDNA: the stock's move on each reportCDNA: the stock's move on each reportJul 30, 2026+23.4%Apr 28, 2026-4.8%Feb 24, 2026-1.8%Nov 4, 2025+11.9%

CareDx's latest quarter

CareDx, Q3 2026: revenue $139M (+39% year over year), operating margin 5.8%, net earnings $19.3M, operating cash flow $12.7M. The chart follows the revenue to costs, profit and cash.

Questions

Did CareDx beat earnings?

CareDx (CDNA) reported on Oct 29, 2026 and beat the EPS estimate: $0.70 against $0.26 (+174.5%).

When does CDNA report earnings?

The next date is not set yet.

Does CareDx usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.